Association of HLA class II genes with susceptibility to Crohn's disease

Gut

Volumn 39, Issue 1, 1996, Pages 69-72

  Danze P M ^a   Colombel, J F ^a   Jacquot, S ^b   Loste, M N ^b   Heresbach, D ^c   Ategbo, S ^a   Khamassi, S ^a   Perichon B ^d   Semana, G ^c   Charron, D ^b   Cezard J P ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Crohn's disease; disease association; HLA class II genes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; FEMALE; GENETIC RISK; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 8944226576     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.1.69     Document Type: Article

References (31)

1. Yang H, Rotter JL. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease. From bench to bedside. Baltimore: Williams and Wilkins, 1994: 32-64.
2. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, Dupas JL, et al. Linkage analysis of chromosome 6 loci, including HLA, in familial aggregations of Crohn's disease. Am J Med Genet 1994; 52: 207-13.
3. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994; 35: 696-700.
4. Fujita K, Naito S, Okabe N, Yao T. Immunological studies in Crohn's disease. I. Association with HLA systems in the Japanese. J Clin Lab Immunol 1984; 14: 99-102.
5. Smolen JS, Gangl A, Polteraeur P, Menzel EJ, Mayr WR. HLA antigens in inflammatory bowel disease. Gastroenterology 1982; 82: 34-8.
6. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, et al. Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993; 104:741-8.
7. Wassmuth R, Keller Y, Thomson G, Starch M, Lindhagen T, Holmberg E, et al. HLA DPB1 alleles provide protection against Crohn's disease in Caucasians. Eur J Gastroenterol Hepatol 1994; 6: 405-11.
8. Boehm BO, Reinshagen M, Loeliger C, Kuehnl P, Adler G. HLA class II genes in Crohn's disease: a population based analysis. Gastroenterology 1994; 106: 654A.
9. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994; 35: 1433-8.
10. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487-91.
11. Yunis I, Salazar M, Yunis EJ. HLA DR genetic typing by AFLP. Tissue Antigens 1991; 38: 78-88.
12. Danzé PM, Bianchi F, Fajardy I, Rousseaux J. An improved strategy for HLA-DRB1 subtyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases. Electrophoresis 1995; 5: 7-13.
13. Gu XF, Elion J, Ouagued M, Clauser E, Assan R, Krishnamoorthy R. A simple strategy to specifically amplify the HLA-DQβ gene region with genomic DNA as template. FEBS Lett 1988; 236: 23-6.
14. Mizuki N, Ohno S, Sugimura K, Seki T, Kikuti YY, Ando A, et al. PCR-RFLP is as sensitive and reliable as PCR-SSO in HLA class II genotyping. Tissue Antigens 1992; 40: 100-3.
15. Thonnard J, Deldime F, Heusterspruete M, Delepaut B, Hanon F, De Bruyère M, et al. HLA class II genotyping: two assay systems compared. Clin Chem 1995; 41: 553-6.
16. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1994; 44: 1-18.
17. Svejgaard A, Jersild C, Nielsen LS, Bodmer WF. HLA antigen and disease: statistical and genetic considerations. Tissue Antigens 1974; 4: 95.
18. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceeding of the eleventh international histocompatibility workshop and conference. Oxford: Oxford Sci, 1992; 1: 1118-26.
19. Sachar DB, Andrews H, Farmer RG, Pallone F, Pena AS, Prantera C, et al. Proposed classification of patient subgroups in Crohn's disease. Working team report 4. Gastroenterol Int 1992; 3: 141-5.
20. Charron D. Molecular basis of human leukocyte antigen class II disease associations. Adv Immunol 1990; 48: 107-58.
21. Manns MP, Krüger M. Immunogenetics of chronic liver disease. Gastroenterology 1994; 106: 1676-97.
22. Heresbach D, Colombel JP, Danzé PM, Semana G. The HLA ORB1*0301 haplotype confers protection against inflammatory bowel disease. Am J Gastroenterol (in press).
23. Nepom GT. A unified hypothesis for the complex genetics of HLA association with IDDM. Diabetes 1990; 39: 1153-7.
24. Schmitt-Egelnolf M, Boehnckc WH, Ständer M, Eiermann TH, Sterry W. Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, - DQA1*0202, -DQB1*0303 extended haplotype. J Invest Dermatol 1993; 100: 749-52.
25. Hughes S, Wiliams SE, Turnberg LA. Crohn's disease and psoriasis. N Engl J Med 1983; 308: 101.
26. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990; 85: 962-3.
27. Wakefield EJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-53.
28. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-5.
29. Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 1994; 89: 1957-62.
30. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, et al. HLA-DRB1*1502 allele, subtype of DR15 is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995; 40: 814-8.
31. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3.